Latest Lead News

Page 11 of 677
Litchfield Minerals has expanded its Harts Range exploration model, raised A$8 million and ended FY2026 with A$4.6 million in cash. The opportunity is growing, but the auditor flagged material uncertainty over the company’s ability to fund future operations.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Sovereign Metals has expanded Kasiya into a potential rutile, graphite and heavy rare earths project, with a rare earths study adding an estimated US$722 million of pre-tax NPV8. The opportunity comes with a sharper execution challenge: Rio Tinto will not become operator, while Sovereign still needs a mining licence, binding offtakes and substantial funding.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Aruma Resources’ 2026 annual report puts the Tillex Copper-Silver Project at the centre of its strategy after wide, high-grade drilling results in Ontario. But the explorer also reported a $2.71 million loss, $788,658 in cash and a material going-concern uncertainty dependent on further capital.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Unity Metals has secured an oversubscribed $3.5 million placement and plans a further $1 million share purchase plan to accelerate drilling across its Cambodian gold projects. The raise gives the explorer funding to test extensions at O’Phlay and new targets at Ngot, but also brings dilution and shareholder-approval hurdles.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Nexsen has proposed a 50:50 joint venture with FlashDx Shenzhen to develop and commercialise an enhanced molecular Group B Streptococcus test, using an existing CE-marked platform as its starting point. The proposed venture could shorten Nexsen’s path into hospital and intrapartum testing across Asia-Pacific, but the term sheet remains non-binding and regulatory work is still ahead.
Victor Sage
Victor Sage
25 Sept 2026
Meeka Metals has secured $40 million after costs through a two-tranche institutional placement priced at $0.10 a share, giving the gold producer fresh funding for Turnberry, Mt Holland and exploration. The capital raise comes as provisional September-quarter gold recovery reached 7,000 to 7,500 ounces and the company expects roughly $50 million in cash after the first tranche.
Maxwell Dee
Maxwell Dee
25 Sept 2026
Big River Industries delivered a stronger FY26 despite subdued residential construction, lifting underlying EBITDA 8.4% and reducing gearing after its Johns Building Supplies acquisition. The company is targeting double-digit underlying EBITDA growth in FY27, while its strategic options review remains unresolved.
Victor Sage
Victor Sage
25 Sept 2026
Flynn Gold is pushing Golden Ridge and Firetower towards resource definition, but its FY2026 annual report flags a material going-concern uncertainty and a cash balance of just A$1.11 million. A partially underwritten A$3 million rights issue now sits alongside drilling, permitting and a non-binding processing pathway with Henty Gold Mine.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Sunshine Metals reduced its annual loss and ended June with $20.6 million in cash, but its auditor flagged a material uncertainty over the company’s ability to continue as a going concern. The warning comes as Sunshine funds the Mt Moss processing conversion, faces a $10 million deferred payment and targets first gold in mid-2027.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Leeuwin Metals ended FY2026 with a 342,300-ounce Marda resource, which increased to 378,600 ounces shortly after year end following further Evanston drilling. The gold explorer is now shifting towards permitting and mine planning, although it remains loss-making, has no Ore Reserves and expects to require further funding.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Legacy Minerals enters FY2027 with a larger Mt Carrington resource, a positive preliminary development study and fresh drilling underway, but the proposed mine still requires substantial funding. The ASX-listed explorer reported a A$1.85 million FY2026 loss and held A$6.07 million in cash at year-end.
Maxwell Dee
Maxwell Dee
24 Sept 2026
Paradigm will return the US$2 million drawn from Obsidian earlier this month and cancel the associated convertible notes, without an additional payment. The decision comes as the biotechnology company reviews interim data from its pivotal knee osteoarthritis trial and prepares a separate update on funding and operations.
Victor Sage
Victor Sage
24 Sept 2026

Browse the archive

Full archive